Cargando…
Integrative genomic analysis of peritoneal malignant mesothelioma: understanding a case with extraordinary chemotherapy response
Peritoneal malignant mesothelioma is a rare disease with a generally poor prognosis and poor response to chemotherapy. To improve survival there is a need for increased molecular understanding of the disease, including chemotherapy sensitivity and resistance. We here present an unusual case concerni...
Autores principales: | Lund-Andersen, Christin, Nakken, Sigve, Nygård, Ståle, Fromm, Bastian, Aasheim, Lars B., Davidson, Ben, Julsrud, Lars, Abrahamsen, Torveig W., Kristensen, Annette T., Dybdahl, Brit, Larsen, Stein G., Hovig, Eivind, Flatmark, Kjersti |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6549577/ https://www.ncbi.nlm.nih.gov/pubmed/30862609 http://dx.doi.org/10.1101/mcs.a003566 |
Ejemplares similares
-
A comprehensive framework for analysis of microRNA sequencing data in metastatic colorectal cancer
por: Høye, Eirik, et al.
Publicado: (2022) -
Personal Cancer Genome Reporter: variant interpretation report for precision oncology
por: Nakken, Sigve, et al.
Publicado: (2018) -
Anti-Angiogenic Treatment in Pseudomyxoma Peritonei—Still a Strong Preclinical Rationale
por: Andersson, Yvonne, et al.
Publicado: (2021) -
Experimental Treatment of Mucinous Peritoneal Metastases Using Patient-Derived Xenograft Models
por: Fleten, Karianne Giller, et al.
Publicado: (2020) -
Clinical relevance of microRNA miR-21, miR-31, miR-92a, miR-101, miR-106a and miR-145 in colorectal cancer
por: Schee, Kristina, et al.
Publicado: (2012)